© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 18, 1490-1499,
September 20, 2000
© 2000 Oxford University Press
Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 5059 Years
Affiliations of authors: A. B. Miller, C. J. Baines, Department of Public Health Sciences, University of Toronto, Canada; T. To, Department of Public Health Sciences, University of Toronto, and Population Health Sciences, The Hospital for Sick Children, Toronto; C. Wall, Institute for Clinical Evaluative Sciences in Ontario, Toronto.
Correspondence to: Anthony B. Miller, M.B., F.R.C.P., Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany (e-mail: A.Miller{at}DKFZ-Heidelberg.de).
Background: Screening for breast cancer with mammography in women aged 50 years or more has been shown to reduce mortality from breast cancer. However, the extent to which mammography contributes to the reduction of mortality in women who also undergo physical examination of the breasts is not known. This study was designed to compare breast cancer mortality following annual screening consisting of two-view mammography and physical examination of the breasts with mortality following annual screening by physical examination only. Breast self-examination was taught to all participants. Methods: This trial randomly and individually assigned 39 405 women aged 5059 years, recruited from January 1980 through March 1985, to one of the study arms. The women were followed by record linkage with the Canadian National Cancer Registry and National Mortality Database to December 31, 1993, and by active follow-up of breast cancer patients to June 30, 1996. Results: Randomization achieved virtually equal distribution of demographic and breast cancer risk variables. At the first annual screen, 21% of the cancers found by mammography alone (in the mammography plus physical examination group) were 20 mm or more in size compared with 46% of those found by physical examination in the mammography plus physical examination group and 56% in the physical examination-only group. The corresponding percentages for screens 25 were 10%, 42%, and 50%, respectively. Screening detected 267 invasive breast cancers in the mammography plus physical examination group compared with 148 in the physical examination-only group. By December 31, 1993, 622 invasive and 71 in situ breast carcinomas were ascertained in the mammography plus physical examination group, and 610 and 16 were ascertained in the physical examination-only group. At 13-year follow-up, with 107 and 105 deaths from breast cancer in the respective groups, the cumulative rate ratio was 1.02 (95% confidence interval = 0.781.33). Conclusion: In women aged 5059 years, the addition of annual mammography screening to physical examination has no impact on breast cancer mortality.
This article has been cited by other articles:
![]() |
H. G. Welch, S. Woloshin, and L. M. Schwartz The Sea of Uncertainty Surrounding Ductal Carcinoma In Situ--The Price of Screening Mammography J Natl Cancer Inst, February 20, 2008; 100(4): 228 - 229. [Full Text] [PDF] |
||||
![]() |
R. L. Ellis, A. A. Meade, M. A. Mathiason, K. M. Willison, and W. Logan-Young Evaluation of Computer-aided Detection Systems in the Detection of Small Invasive Breast Carcinoma Radiology, October 1, 2007; 245(1): 88 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Devi, T. Tang, and M Corbex Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia Ann. Onc., July 1, 2007; 18(7): 1172 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. G. L. Tan, G. J. van Oortmarssen, H. J. de Koning, R. Boer, and J. D. F. Habbema Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 56 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Clarke, S. K. Plevritis, R. Boer, K. A. Cronin, and E. J. Feuer Chapter 13: A Comparative Review of CISNET Breast Models Used To Analyze U.S. Breast Cancer Incidence and Mortality Trends J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 96 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Elmore, N. S. Weiss, W. E. Barlow, S. W. Fletcher, L. M. Reisch, M. B. Barton, S. J. Rolnick, S. M. Greene, and G. Hart RESPONSE: Re: Efficacy of Breast Cancer Screening in the Community According to Risk Level J Natl Cancer Inst, November 16, 2005; 97(22): 1704 - 1705. [Full Text] [PDF] |
||||
![]() |
D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. F. Habbema, E. J. Feuer, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med., October 27, 2005; 353(17): 1784 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen, Y. Yang, L. Y. T. Inoue, M. F. Munsell, A. B. Miller, and D. A. Berry Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening Trials J Natl Cancer Inst, August 17, 2005; 97(16): 1195 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher Screening for Breast Cancer JAMA, March 9, 2005; 293(10): 1245 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Khan, E. L. Wiley, N. Rodriguez, C. Baird, R. Ramakrishnan, R. Nayar, M. Bryk, K. B. Bethke, V. L. Staradub, J. Wolfman, et al. Ductal Lavage Findings in Women With Known Breast Cancer Undergoing Mastectomy J Natl Cancer Inst, October 20, 2004; 96(20): 1510 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Leonard and S. M. Swain Ductal Carcinoma In Situ, Complexities and Challenges J Natl Cancer Inst, June 16, 2004; 96(12): 906 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A Freedman, D. B Petitti, and J. M Robins On the efficacy of screening for breast cancer Int. J. Epidemiol., February 1, 2004; 33(1): 43 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B Miller Commentary: A defence of the Health Insurance Plan (HIP) study and the Canadian National Breast Screening Study (CNBSS) Int. J. Epidemiol., February 1, 2004; 33(1): 64 - 65. [Full Text] [PDF] |
||||
![]() |
C. J. Baines Mammography Screening: Are Women Really Giving Informed Consent? J Natl Cancer Inst, October 15, 2003; 95(20): 1508 - 1511. [Full Text] [PDF] |
||||
![]() |
R. A. Smith, D. Saslow, K. Andrews Sawyer, W. Burke, M. E. Costanza, W. P. Evans III, R. S. Foster Jr., E. Hendrick, H. J. Eyre, and S. Sener American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 CA Cancer J Clin, May 1, 2003; 53(3): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pichert, B. Bolliger, K. Buser, and O. Pagani Evidence-based management options for women at increased breast/ovarian cancer risk Ann. Onc., January 1, 2003; 14(1): 9 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. ROQUE and T. C.S.S. ANDRE Mammography and Computerized Decision Systems: A Review Ann. N.Y. Acad. Sci., December 1, 2002; 980(1): 83 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
D G R Evans and F Lalloo Risk assessment and management of high risk familial breast cancer J. Med. Genet., December 1, 2002; 39(12): 865 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Leung, T.-H. Lam, T. Q. Thach, and A. J. Hedley Will Screening Mammography in the East Do More Harm than Good? Am J Public Health, November 1, 2002; 92(11): 1841 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Ernster, R. Ballard-Barbash, W. E. Barlow, Y. Zheng, D. L. Weaver, G. Cutter, B. C. Yankaskas, R. Rosenberg, P. A. Carney, K. Kerlikowske, et al. Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography J Natl Cancer Inst, October 16, 2002; 94(20): 1546 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Harris and L. S. Kinsinger Routinely Teaching Breast Self-Examination is Dead. What Does This Mean? J Natl Cancer Inst, October 2, 2002; 94(19): 1420 - 1421. [Full Text] [PDF] |
||||
![]() |
A. B. Miller, T. To, C. J. Baines, and C. Wall The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years Ann Intern Med, September 3, 2002; 137(5_Part_1): 305 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Humphrey, M. Helfand, B. K.S. Chan, and S. H. Woolf Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, September 3, 2002; 137(5_Part_1): 347 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Schwartz and S. Woloshin News Media Coverage of Screening Mammography for Women in Their 40s and Tamoxifen for Primary Prevention of Breast Cancer JAMA, June 19, 2002; 287(23): 3136 - 3142. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Begg The Mammography Controversy Oncologist, June 1, 2002; 7(3): 174 - 176. [Full Text] [PDF] |
||||
![]() |
S. A. Feig Image Quality of Screening Mammography: Effect on Clinical Outcome Am. J. Roentgenol., April 1, 2002; 178(4): 805 - 807. [Full Text] [PDF] |
||||
![]() |
W. C. Black, D. A. Haggstrom, and H. Gilbert Welch All-Cause Mortality in Randomized Trials of Cancer Screening J Natl Cancer Inst, February 6, 2002; 94(3): 167 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Clifford, M. Sampson, and H. M. Schachter Breast self-examination Can. Med. Assoc. J., January 1, 2002; 166(2): 164 - 164. [Full Text] |
||||
![]() |
N. Baxter Breast self-examination Can. Med. Assoc. J., January 1, 2002; 166(2): 166 - 168. [Full Text] |
||||
![]() |
L. Berlin Dot Size, Lead Time, Fallibility, and Impact on Survival: Continuing Controversies in Mammography Am. J. Roentgenol., May 1, 2001; 176(5): 1123 - 1130. [Full Text] [PDF] |
||||
![]() |
L. Berlin The Missed Breast Cancer Redux: Time for Educating the Public About the Limitations of Mammography? Am. J. Roentgenol., May 1, 2001; 176(5): 1131 - 1134. [Full Text] [PDF] |
||||
![]() |
C J M de Wolf, G Q. della Rovere, R. Warren, A B Miller, and C J Baines Detection of breast cancer BMJ, March 31, 2001; 322(7289): 792a - 792. [Full Text] |
||||
![]() |
S. A. Narod Re: Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years J Natl Cancer Inst, March 7, 2001; 93(5): 396 - 396. [Full Text] [PDF] |
||||
![]() |
A. B. Miller, C. J. Baines, and C. Wall RESPONSE: Re: Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years J Natl Cancer Inst, March 7, 2001; 93(5): 396a - 397a. [Full Text] [PDF] |
||||
![]() |
A. B Miller, S. Rozenberg, B. Carly, F. Liebens, H. Ham, M. Baum, and J S Tobias Effect of screening programme on mortality from breast cancer BMJ, December 16, 2000; 321(7275): 1527a - 1527. [Full Text] |
||||
![]() |
I. Mittra, M. Baum, H. Thornton, and J. Houghton Is clinical breast examination an acceptable alternative to mammographic screening? BMJ, October 28, 2000; 321(7268): 1071 - 1073. [Full Text] |
||||
![]() |
A Controversial Mammography Study Resurfaces Journal Watch (General), October 6, 2000; 2000(1006): 1 - 1. [Full Text] |
||||
![]() |
A. B. Miller Organized breast cancer screening programs in Canada Can. Med. Assoc. J., October 1, 2000; 163(9): 1150 - 1151. [Full Text] [PDF] |
||||
















